These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25368261)

  • 1. End-of-life pain medication among cancer patients in hospice settings.
    Koivu L; Pölönen T; Stormi T; Salminen E
    Anticancer Res; 2014 Nov; 34(11):6581-4. PubMed ID: 25368261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent subcutaneous injections for symptom control in hospice care: a retrospective investigation.
    Letizia M; Shenk J; Jones TD
    Hosp J; 2000; 15(2):1-11. PubMed ID: 11271156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids, survival, and advanced cancer in the hospice setting.
    Azoulay D; Jacobs JM; Cialic R; Mor EE; Stessman J
    J Am Med Dir Assoc; 2011 Feb; 12(2):129-34. PubMed ID: 21266289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use in dying patients in hospice and hospital, with and without specialist palliative care team involvement.
    Brown W
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):65-71. PubMed ID: 18181893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid use and survival at the end of life: a survey of a hospice population.
    Portenoy RK; Sibirceva U; Smout R; Horn S; Connor S; Blum RH; Spence C; Fine PG
    J Pain Symptom Manage; 2006 Dec; 32(6):532-40. PubMed ID: 17157755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors that enable the patients to live their life till death at home by controlling cancer-pains with continuous subcutaneous injection of opioids-case reports of 3 patients with a terminal cancer].
    Yoshimura M; Takeu R
    Gan To Kagaku Ryoho; 2001 Dec; 28 Suppl 1():110-3. PubMed ID: 11787275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward evidence-based prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients.
    Weschules DJ; Bain KT; Reifsnyder J; McMath JA; Kupperman DE; Gallagher RM; Hauck WW; Knowlton CH
    Pain Med; 2006; 7(4):320-9. PubMed ID: 16898943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
    Lundorff L; Peuckmann V; Sjøgren P
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?
    Bercovitch M; Adunsky A
    Cancer; 2004 Sep; 101(6):1473-7. PubMed ID: 15368335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of opioid use in a population of cancer patients during the trajectory of the disease.
    Jarlbaek L; Hansen DG; Bruera E; Andersen M
    Clin Oncol (R Coll Radiol); 2010 Apr; 22(3):199-207. PubMed ID: 20045301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of strong opioids in advanced cancer pain: a randomized trial.
    Marinangeli F; Ciccozzi A; Leonardis M; Aloisio L; Mazzei A; Paladini A; Porzio G; Marchetti P; Varrassi G
    J Pain Symptom Manage; 2004 May; 27(5):409-16. PubMed ID: 15120769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fentanyl transdermal system. Pain management at home.
    Woodroffe MA; Hays H
    Can Fam Physician; 1997 Feb; 43():268-72. PubMed ID: 9040914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of intolerable sufferings in a hospice unit].
    Rosland JH; Saunes TK; Bull AN
    Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2661-4. PubMed ID: 17952148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain management at the end of life: A comparative study of cancer, dementia, and chronic obstructive pulmonary disease patients.
    Romem A; Tom SE; Beauchene M; Babington L; Scharf SM; Romem A
    Palliat Med; 2015 May; 29(5):464-9. PubMed ID: 25680377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of pain control in cancer patients during the last week of life: comparison of health centre wards and a hospice.
    Hinkka H; Kosunen E; Kellokumpu-Lehtinen P; Lammi UK
    Support Care Cancer; 2001 Sep; 9(6):428-34. PubMed ID: 11585269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regional survey of opioid use by patients receiving specialist palliative care.
    Brooks DJ; Gamble W; Ahmedzai S
    Palliat Med; 1995 Jul; 9(3):229-38. PubMed ID: 7582179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids for cancer breakthrough pain: a pilot study reporting patient assessment of time to meaningful pain relief.
    Zeppetella G
    J Pain Symptom Manage; 2008 May; 35(5):563-7. PubMed ID: 18258412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain.
    Dougherty M; DeBaun MR
    J Pediatr; 2003 Apr; 142(4):373-6. PubMed ID: 12712053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose daily opioid administration and poor functional status intensify local anesthetic injection pain in cancer patients.
    Kim SH; Yoon DM; Choi KW; Yoon KB
    Pain Physician; 2013; 16(3):E247-56. PubMed ID: 23703423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.